Molecular effects of Mastodynon: realities and prospects for cancer prevention
https://doi.org/10.17650/1994-4098-2022-18-3-107-111
Abstract
The article presents updated data concerning the molecular mechanisms of influence of the well-known in clinical practice drug Mastodynon. The paper provides evidence of a significant effect of the compounds containing in its composition on the cell lines of a number of malignant neoplasms: breast cancer, hepatocellular carcinoma, leukemia and others. The data obtained are extremely attractive in the perspective of using the drug as a preventive agent.
About the Authors
I. V. Vysotskaya
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Irina Viktorovna Vysotskaya
Build. 2, 8 Trubetskaya St., Moscow 119991
E. A. Kim
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
V. Yu. Kirsanov
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
S. B. Polikarpova
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
V. E. Ponomarev
I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Build. 2, 8 Trubetskaya St., Moscow 119991
References
1. Global website of the World Health Organization. Available at: https://www.who.int/en
2. Sasaki Y., Takagi K., Akashira J.-I. et al. Immunolocalisation or estrogen-producing and metabolizing enzymes in bening breast disease: comparison with normal breast and breast сarcinoma. JCA 2010;101(10):2286–92. DOI: 10.1111/j.1349-7006.2010.01673.x
3. Kogan I.Yu. Mastopathy, new approaches to diagnostics and pathogenetic therapy. Journal of Zhurnal akusherstva i zheskikh bolezney = Obstetrics and Women’s Diseases 2010;LIX(1):66–70. (In Russ.)
4. Madaus G. Lehrbuch der biologischen Heilmittel. 4 Bände. Thieme, Leipzig, 1938.
5. Panay N. Guidelines on Premenstrual Syndrome. The National Association for Premenstrual Syndrome (NAPS), 2016. Available at: http://www.pms.org.uk/assets/files/guidelinesfinal60210.pdf
6. Vysotskaya I.V., Letyagin V.P., Cherenkov V.G. et al. Clinical recommendations of the Russian Society of oncomammologists for the prevention of breast cancer, differential diagnosis, treatment of precancerous and benign diseases of the mammary glands. Opukholi zhenskoy reproduktivnoy systemy = Tumors of female reproductive system 2016;3(12):43–52. (In Russ.)
7. Vysotskaya I.V., Letyagin V.P. Benign diseases of the mammary glands. 2nd edn. Moscow: SIMK, 2019. 103 p. (In Russ.)
8. Benign Dysplasia of the Mammary Gland. Clinical Recommendations of the Ministry of Health of Russia, 2020. Available at: http://cr.rosminzdrav.ru/#!/schema/1027. (In Russ.)
9. Zhou Y., Tian L., Long L. et al. Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. PLoS One 2013;8(3):e58855. DOI: 10.1371/journal.pone.0058855
10. Zhou Y., Peng Y., Mao Q.Q. et al. Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells. Asian Pac J Trop Med 2013;6(5): 372–8. DOI: 10.1016/S1995-7645(13)60041-3
11. Kikuchi H., Yuan B., Nishimura Y. et al. Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines. Int J Oncol 2013;43(6):1976–84. DOI: 10.3892/ijo.2013.2133
12. Li W.X., Cui C.B., Cai B. et al. Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G2/M phase and induce apoptosis in mammalian cancer cells. J Asian Nat Prod Res 2005;7(4):615– 26. DOI: 10.1080/10286020310001625085
13. Chan E.W.C., Wong S.K., Chan H.T.J. Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties Integr Med 2018;16(3):147–52. DOI: 10.1016/j.joim.2018.03.001
14. Ramchandani S., Naz I., Lee J.H. et al. An overview of the potential antineoplastic effects of casticin molecules. Molecules 2020;25(6):1287. DOI: 10.3390/molecules25061287
15. Jiang L., Cao X., Cao J. et al. Casticin induces ovarian cancer cell apoptosis by repressing FoxM1 through the activation of FOXO3a. Oncol Lett 2013;5;1605–10. DOI: 10.3892/ol.2013. 1258
16. Bischoff-Kont I., Brabenec L., Ingelfinger R. BNO1095, a standardized dry extract from the fruits of Vitex agnus-castus, impairs angiogenesis-related endothelial cellsfunction in vitro. Planta Med 2021;87:611–9. DOI: 1055/а-1351-1038
Review
For citations:
Vysotskaya I.V., Kim E.A., Kirsanov V.Yu., Polikarpova S.B., Ponomarev V.E. Molecular effects of Mastodynon: realities and prospects for cancer prevention. Tumors of female reproductive system. 2022;18(3):107-111. (In Russ.) https://doi.org/10.17650/1994-4098-2022-18-3-107-111
Views:
954
Email this article 